These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 18553082)

  • 1. Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation.
    Ohbayashi Y; Imataki O; Ohnishi H; Iwasaki A; Ogawa T; Inagaki N; Shigeta H; Ohue Y; Tasaka T; Kitanaka A; Kubota Y; Tanaka T; Ishida T; Miyake M
    Ann Hematol; 2008 Oct; 87(10):837-45. PubMed ID: 18553082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group.
    Gori E; Arpinati M; Bonifazi F; Errico A; Mega A; Alberani F; Sabbi V; Costazza G; Leanza S; Borrelli C; Berni M; Feraut C; Polato E; Altieri MC; Pirola E; Loddo MC; Banfi M; Barzetti L; Calza S; Brignoli C; Bandini G; De Vivo A; Bosi A; Baccarani M
    Bone Marrow Transplant; 2007 Mar; 39(6):347-52. PubMed ID: 17277790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens.
    Kashiwazaki H; Matsushita T; Sugita J; Shigematsu A; Kasashi K; Yamazaki Y; Kanehira T; Kondo T; Endo T; Tanaka J; Hashino S; Nishio M; Imamura M; Kitagawa Y; Inoue N
    Support Care Cancer; 2012 May; 20(5):933-9. PubMed ID: 21494780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-l-PAM 200 mg/m(2) autologous hematopoietic stem cell transplantation.
    Vokurka S; Bystricka E; Scudlova J; Mazur E; Visokaiova M; Vasilieva E; Brandejsova R; Chvojkova I; Vrabcova M; Vitkova J; Mjartanova D; Vodickova M; Bockova J; Streinerova K
    Eur J Oncol Nurs; 2011 Dec; 15(5):508-12. PubMed ID: 21310656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
    Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
    J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation.
    Elad S; Ackerstein A; Bitan M; Shapira MY; Resnick I; Gesundheit B; Cohen Y; Diss O; Barak D; Dray L; Or R
    Bone Marrow Transplant; 2006 Apr; 37(8):757-62. PubMed ID: 16518424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen.
    Kojima R; Kami M; Nannya Y; Kusumi E; Sakai M; Tanaka Y; Kanda Y; Mori S; Chiba S; Miyakoshi S; Tajima K; Hirai H; Taniguchi S; Sakamaki H; Takaue Y
    Biol Blood Marrow Transplant; 2004 Sep; 10(9):645-52. PubMed ID: 15319776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model.
    Grazziutti ML; Dong L; Miceli MH; Krishna SG; Kiwan E; Syed N; Fassas A; van Rhee F; Klaus H; Barlogie B; Anaissie EJ
    Bone Marrow Transplant; 2006 Oct; 38(7):501-6. PubMed ID: 16980998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-energy laser therapy for prevention of oral mucositis in hematopoietic stem cell transplantation.
    Jaguar GC; Prado JD; Nishimoto IN; Pinheiro MC; de Castro DO; da Cruz Perez DE; Alves FA
    Oral Dis; 2007 Nov; 13(6):538-43. PubMed ID: 17944669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.
    Freytes CO; Ratanatharathorn V; Taylor C; Abboud C; Chesser N; Restrepo A; Arango J; Odenheimer D
    Clin Cancer Res; 2004 Dec; 10(24):8318-24. PubMed ID: 15623608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a standardized protocol for prevention and management of oral mucositis in patients undergoing hematopoietic cell transplantation.
    Bhatt V; Vendrell N; Nau K; Crumb D; Roy V
    J Oncol Pharm Pract; 2010 Sep; 16(3):195-204. PubMed ID: 19910393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation.
    Bolwell BJ; Kalaycio M; Sobecks R; Andresen S; Kuczkowski E; Bernhard L; Lomax R; Kohuth J; Mendiola S; Rybicki L; Pohlman B
    Bone Marrow Transplant; 2002 Nov; 30(9):587-91. PubMed ID: 12407433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of low power laser in the treatment of conditioning-induced oral mucositis: a report of 11 clinical cases and their review.
    Antunes HS; Ferreira EM; de Matos VD; Pinheiro CT; Ferreira CG
    Med Oral Patol Oral Cir Bucal; 2008 Mar; 13(3):E189-92. PubMed ID: 18305441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy: the effect of oral cryotherapy on the development of mucositis.
    Karagözoğlu S; Filiz Ulusoy M
    J Clin Nurs; 2005 Jul; 14(6):754-65. PubMed ID: 15946284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST).
    Yamamoto R; Kusumi E; Kami M; Yuji K; Hamaki T; Saito A; Murasgihe N; Hori A; Kim SW; Makimoto A; Ueyama J; Tanosaki R; Miyakoshi S; Mori S; Morinaga S; Heike Y; Taniguchi S; Masuo S; Takaue Y; Mutou Y
    Bone Marrow Transplant; 2003 Dec; 32(11):1089-95. PubMed ID: 14625581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral mucositis.
    Scully C; Sonis S; Diz PD
    Oral Dis; 2006 May; 12(3):229-41. PubMed ID: 16700732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral cryotherapy for oral mucositis management in patients receiving allogeneic hematopoietic stem cell transplantation: a prospective randomized study.
    Lu Y; Zhu X; Ma Q; Wang J; Jiang P; Teng S; Zhou L; Wu D; Wang H
    Support Care Cancer; 2020 Apr; 28(4):1747-1754. PubMed ID: 31302767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients.
    Langner S; Staber P; Schub N; Gramatzki M; Grothe W; Behre G; Rabitsch W; Urban C; Linkesch W; Neumeister P
    Bone Marrow Transplant; 2008 Aug; 42(4):275-9. PubMed ID: 18500368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cryotherapy is useful and safe in the prevention of oral mucositis after high-dose melphalan (L-PAM)].
    Inagaki N; Ohue Y; Shigeta H; Tasaka T
    Rinsho Ketsueki; 2006 Nov; 47(11):1469-71. PubMed ID: 17176891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma.
    Batlle M; Morgades M; Vives S; Ferrà C; Oriol A; Sancho JM; Xicoy B; Moreno M; Magallón L; Ribera JM
    Eur J Haematol; 2014 Dec; 93(6):487-91. PubMed ID: 24889275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.